Rhumbline Advisers »

Forte Biosciences shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $471k 22k 21.25

More positions owned by Rhumbline Advisers

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Micron Technology (MU)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Visa (V)

View all positions for Rhumbline Advisers

Top funds holding Forte Biosciences

Federated Investors
OrbiMed Advisors
Fred Alger Management
Jupiter Topco
BlackRock
Henderson Group
Affinity Asset Advisors
MPM Oncology Impact Management
TCG Crossover Management
Vanguard Capital Management
Woodline Partners
Adage Capital Partners GP
Integral Health Asset Management
Millennium Management
Citadel Advisors

View all funds holding Forte Biosciences